MULTIPLE VIEW MARKETING ANALYSIS OF THE RUSSIAN PLANT-BASED DRUGS MARKET
The received results show that the greatest (79%) share of plant-based drugs is presented by the domestic manufacturers. The greatest contribution (more than 13%) in structure of import supply is made by the European manufacturing enterprises. Germany (6.86%) is leading among them. The presentation...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The received results show that the greatest (79%) share of plant-based drugs is presented by the domestic manufacturers. The greatest contribution (more than 13%) in structure of import supply is made by the European manufacturing enterprises. Germany (6.86%) is leading among them. The presentation of botanical drugs (31.54%) is the most frequent. One can’t help paying attention to the fraction of substances (7.67%) and semi-finished products (10.17%) in structure of import supply. The latter the indicates the dependence of domestic manufacturers on supply of raw materials from abroad. It is important to notice the share (19.87%) of medicines for digestive tract diseases and metabolic disorders treatment. |
|---|---|
| ISSN: | 2305-2066 2658-5049 |